
110.53 Delayed Data As of Jan 15 | ![]() Today’s Change | 62.55 Today|||52-Week Range 113.41 | +3.15% Year-to-Date |
Editas (EDIT) Up More Than 100% in Past 3 Months: Here's Why Jan 18 / Zacks.com - Paid Partner Content | 3 Great Dividend Stocks That Are Simply Too Cheap to Ignore Jan 14 / MotleyFool.com - Paid Partner Content |
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines) Jan 17 / MotleyFool.com - Paid Partner Content | AbbVie (ABBV) Inks Deal to Acquire Medical Device Company Jan 13 / Zacks.com - Paid Partner Content |
3 Green Flags for AbbVie in 2021 and 1 Red Flag Jan 15 / MotleyFool.com - Paid Partner Content | These 3 Value Stocks Are Absurdly Cheap Right Now Jan 13 / MotleyFool.com - Paid Partner Content |
5 Top Healthcare Stocks for 2021 Jan 15 / StockNews.com - Paid Partner Content | 3 Dividend Aristocrats to Buy Right Now Jan 13 / MotleyFool.com - Paid Partner Content |
AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Jan 14 / Zacks.com - Paid Partner Content | AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Jan 12 / Zacks.com - Paid Partner Content |
Previous close | 110.52 |
Today’s open | 111.11 |
Day’s range | 109.53 - 111.54 |
Volume | 3,302 |
Average volume (3 months) | 7,930,378 |
Market cap | $195.1B |
Earnings growth (last year) | +44.28% |
Earnings growth (this year) | +17.29% |
Earnings growth (next 5 years) | +5.71% |
Revenue growth (last year) | +1.57% |
P/E ratio | 23.8 |
Price/Sales | 3.95 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
PFEPfizer | +0.00 | +0.01% |
LLYEli Lilly and Co | +0.17 | +0.09% |
MRKMerck | +1.21 | +1.47% |
NVSNovartis | +1.01 | +1.07% |
Next reporting date | February 3, 2021 |
EPS forecast (this quarter) | $2.86 |
Annual revenue (last year) | $33.3B |
Annual profit (last year) | $7.8B |
Net profit margin | 23.57% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |